Serum albumin-binding fibronectin type III domains | Patent Number 11833190

US 11833190 B2
Application Number17153229
Publication NumberUS 20210228688 A1
Pendency2 years, 10 months, 19 days
Filled DateJan 20, 2021
Priority DateJun 3, 2016
Publication DateJul 29, 2021
Expiration DateJun 2, 2036
Inventor/ApplicantsMichael Diem
Thomas Rutkoski
Steven Jacobs
Karyn O'Neil
ExaminesBUNNER, BRIDGET E
Art Unit1647
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.